Copyright Reports & Markets. All rights reserved.

Global Gold Nanoparticles in Biology and Medicine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Gold Nanoparticles in Biology and Medicine Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Water Soluble Gold Nanoparticles
    • 1.3.3 Oil Soluble Gold Nanoparticles
    • 1.3.4 Both Phase Soluble Gold Nanoparticles
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Gold Nanoparticles in Biology and Medicine Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Biology
    • 1.4.3 Medicine
  • 1.5 Global Gold Nanoparticles in Biology and Medicine Market Size & Forecast
    • 1.5.1 Global Gold Nanoparticles in Biology and Medicine Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Gold Nanoparticles in Biology and Medicine Sales Quantity (2020-2031)
    • 1.5.3 Global Gold Nanoparticles in Biology and Medicine Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Nanopartz
    • 2.1.1 Nanopartz Details
    • 2.1.2 Nanopartz Major Business
    • 2.1.3 Nanopartz Gold Nanoparticles in Biology and Medicine Product and Services
    • 2.1.4 Nanopartz Gold Nanoparticles in Biology and Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Nanopartz Recent Developments/Updates
  • 2.2 Nanocs
    • 2.2.1 Nanocs Details
    • 2.2.2 Nanocs Major Business
    • 2.2.3 Nanocs Gold Nanoparticles in Biology and Medicine Product and Services
    • 2.2.4 Nanocs Gold Nanoparticles in Biology and Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Nanocs Recent Developments/Updates
  • 2.3 nanoComposix
    • 2.3.1 nanoComposix Details
    • 2.3.2 nanoComposix Major Business
    • 2.3.3 nanoComposix Gold Nanoparticles in Biology and Medicine Product and Services
    • 2.3.4 nanoComposix Gold Nanoparticles in Biology and Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 nanoComposix Recent Developments/Updates
  • 2.4 BBI Solutions
    • 2.4.1 BBI Solutions Details
    • 2.4.2 BBI Solutions Major Business
    • 2.4.3 BBI Solutions Gold Nanoparticles in Biology and Medicine Product and Services
    • 2.4.4 BBI Solutions Gold Nanoparticles in Biology and Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 BBI Solutions Recent Developments/Updates
  • 2.5 Cline Scientific
    • 2.5.1 Cline Scientific Details
    • 2.5.2 Cline Scientific Major Business
    • 2.5.3 Cline Scientific Gold Nanoparticles in Biology and Medicine Product and Services
    • 2.5.4 Cline Scientific Gold Nanoparticles in Biology and Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Cline Scientific Recent Developments/Updates
  • 2.6 Cytodiagnostics
    • 2.6.1 Cytodiagnostics Details
    • 2.6.2 Cytodiagnostics Major Business
    • 2.6.3 Cytodiagnostics Gold Nanoparticles in Biology and Medicine Product and Services
    • 2.6.4 Cytodiagnostics Gold Nanoparticles in Biology and Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Cytodiagnostics Recent Developments/Updates
  • 2.7 Sigma Aldrich
    • 2.7.1 Sigma Aldrich Details
    • 2.7.2 Sigma Aldrich Major Business
    • 2.7.3 Sigma Aldrich Gold Nanoparticles in Biology and Medicine Product and Services
    • 2.7.4 Sigma Aldrich Gold Nanoparticles in Biology and Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Sigma Aldrich Recent Developments/Updates
  • 2.8 Tanaka Technologies
    • 2.8.1 Tanaka Technologies Details
    • 2.8.2 Tanaka Technologies Major Business
    • 2.8.3 Tanaka Technologies Gold Nanoparticles in Biology and Medicine Product and Services
    • 2.8.4 Tanaka Technologies Gold Nanoparticles in Biology and Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Tanaka Technologies Recent Developments/Updates
  • 2.9 Expedeon
    • 2.9.1 Expedeon Details
    • 2.9.2 Expedeon Major Business
    • 2.9.3 Expedeon Gold Nanoparticles in Biology and Medicine Product and Services
    • 2.9.4 Expedeon Gold Nanoparticles in Biology and Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Expedeon Recent Developments/Updates
  • 2.10 NanoSeedz
    • 2.10.1 NanoSeedz Details
    • 2.10.2 NanoSeedz Major Business
    • 2.10.3 NanoSeedz Gold Nanoparticles in Biology and Medicine Product and Services
    • 2.10.4 NanoSeedz Gold Nanoparticles in Biology and Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 NanoSeedz Recent Developments/Updates
  • 2.11 NanoHybrids
    • 2.11.1 NanoHybrids Details
    • 2.11.2 NanoHybrids Major Business
    • 2.11.3 NanoHybrids Gold Nanoparticles in Biology and Medicine Product and Services
    • 2.11.4 NanoHybrids Gold Nanoparticles in Biology and Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 NanoHybrids Recent Developments/Updates
  • 2.12 Hongwu New Material
    • 2.12.1 Hongwu New Material Details
    • 2.12.2 Hongwu New Material Major Business
    • 2.12.3 Hongwu New Material Gold Nanoparticles in Biology and Medicine Product and Services
    • 2.12.4 Hongwu New Material Gold Nanoparticles in Biology and Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Hongwu New Material Recent Developments/Updates
  • 2.13 Metalor Technologies SA
    • 2.13.1 Metalor Technologies SA Details
    • 2.13.2 Metalor Technologies SA Major Business
    • 2.13.3 Metalor Technologies SA Gold Nanoparticles in Biology and Medicine Product and Services
    • 2.13.4 Metalor Technologies SA Gold Nanoparticles in Biology and Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Metalor Technologies SA Recent Developments/Updates
  • 2.14 Solaris Nanoscinces
    • 2.14.1 Solaris Nanoscinces Details
    • 2.14.2 Solaris Nanoscinces Major Business
    • 2.14.3 Solaris Nanoscinces Gold Nanoparticles in Biology and Medicine Product and Services
    • 2.14.4 Solaris Nanoscinces Gold Nanoparticles in Biology and Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Solaris Nanoscinces Recent Developments/Updates
  • 2.15 Meliorum Technologies
    • 2.15.1 Meliorum Technologies Details
    • 2.15.2 Meliorum Technologies Major Business
    • 2.15.3 Meliorum Technologies Gold Nanoparticles in Biology and Medicine Product and Services
    • 2.15.4 Meliorum Technologies Gold Nanoparticles in Biology and Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Meliorum Technologies Recent Developments/Updates

3 Competitive Environment: Gold Nanoparticles in Biology and Medicine by Manufacturer

  • 3.1 Global Gold Nanoparticles in Biology and Medicine Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Gold Nanoparticles in Biology and Medicine Revenue by Manufacturer (2020-2025)
  • 3.3 Global Gold Nanoparticles in Biology and Medicine Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Gold Nanoparticles in Biology and Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Gold Nanoparticles in Biology and Medicine Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Gold Nanoparticles in Biology and Medicine Manufacturer Market Share in 2024
  • 3.5 Gold Nanoparticles in Biology and Medicine Market: Overall Company Footprint Analysis
    • 3.5.1 Gold Nanoparticles in Biology and Medicine Market: Region Footprint
    • 3.5.2 Gold Nanoparticles in Biology and Medicine Market: Company Product Type Footprint
    • 3.5.3 Gold Nanoparticles in Biology and Medicine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Gold Nanoparticles in Biology and Medicine Market Size by Region
    • 4.1.1 Global Gold Nanoparticles in Biology and Medicine Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Gold Nanoparticles in Biology and Medicine Consumption Value by Region (2020-2031)
    • 4.1.3 Global Gold Nanoparticles in Biology and Medicine Average Price by Region (2020-2031)
  • 4.2 North America Gold Nanoparticles in Biology and Medicine Consumption Value (2020-2031)
  • 4.3 Europe Gold Nanoparticles in Biology and Medicine Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Gold Nanoparticles in Biology and Medicine Consumption Value (2020-2031)
  • 4.5 South America Gold Nanoparticles in Biology and Medicine Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Gold Nanoparticles in Biology and Medicine Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Gold Nanoparticles in Biology and Medicine Sales Quantity by Type (2020-2031)
  • 5.2 Global Gold Nanoparticles in Biology and Medicine Consumption Value by Type (2020-2031)
  • 5.3 Global Gold Nanoparticles in Biology and Medicine Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Gold Nanoparticles in Biology and Medicine Sales Quantity by Application (2020-2031)
  • 6.2 Global Gold Nanoparticles in Biology and Medicine Consumption Value by Application (2020-2031)
  • 6.3 Global Gold Nanoparticles in Biology and Medicine Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Gold Nanoparticles in Biology and Medicine Sales Quantity by Type (2020-2031)
  • 7.2 North America Gold Nanoparticles in Biology and Medicine Sales Quantity by Application (2020-2031)
  • 7.3 North America Gold Nanoparticles in Biology and Medicine Market Size by Country
    • 7.3.1 North America Gold Nanoparticles in Biology and Medicine Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Gold Nanoparticles in Biology and Medicine Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Gold Nanoparticles in Biology and Medicine Sales Quantity by Type (2020-2031)
  • 8.2 Europe Gold Nanoparticles in Biology and Medicine Sales Quantity by Application (2020-2031)
  • 8.3 Europe Gold Nanoparticles in Biology and Medicine Market Size by Country
    • 8.3.1 Europe Gold Nanoparticles in Biology and Medicine Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Gold Nanoparticles in Biology and Medicine Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Gold Nanoparticles in Biology and Medicine Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Gold Nanoparticles in Biology and Medicine Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Gold Nanoparticles in Biology and Medicine Market Size by Region
    • 9.3.1 Asia-Pacific Gold Nanoparticles in Biology and Medicine Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Gold Nanoparticles in Biology and Medicine Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Gold Nanoparticles in Biology and Medicine Sales Quantity by Type (2020-2031)
  • 10.2 South America Gold Nanoparticles in Biology and Medicine Sales Quantity by Application (2020-2031)
  • 10.3 South America Gold Nanoparticles in Biology and Medicine Market Size by Country
    • 10.3.1 South America Gold Nanoparticles in Biology and Medicine Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Gold Nanoparticles in Biology and Medicine Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Gold Nanoparticles in Biology and Medicine Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Gold Nanoparticles in Biology and Medicine Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Gold Nanoparticles in Biology and Medicine Market Size by Country
    • 11.3.1 Middle East & Africa Gold Nanoparticles in Biology and Medicine Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Gold Nanoparticles in Biology and Medicine Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Gold Nanoparticles in Biology and Medicine Market Drivers
  • 12.2 Gold Nanoparticles in Biology and Medicine Market Restraints
  • 12.3 Gold Nanoparticles in Biology and Medicine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Gold Nanoparticles in Biology and Medicine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Gold Nanoparticles in Biology and Medicine
  • 13.3 Gold Nanoparticles in Biology and Medicine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Gold Nanoparticles in Biology and Medicine Typical Distributors
  • 14.3 Gold Nanoparticles in Biology and Medicine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Gold Nanoparticles in Biology and Medicine market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
    This report is a detailed and comprehensive analysis for global Gold Nanoparticles in Biology and Medicine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Gold Nanoparticles in Biology and Medicine market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
    Global Gold Nanoparticles in Biology and Medicine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
    Global Gold Nanoparticles in Biology and Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2020-2031
    Global Gold Nanoparticles in Biology and Medicine market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Gold Nanoparticles in Biology and Medicine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Gold Nanoparticles in Biology and Medicine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nanopartz, Nanocs, nanoComposix, BBI Solutions, Cline Scientific, Cytodiagnostics, Sigma Aldrich, Tanaka Technologies, Expedeon, NanoSeedz, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Gold Nanoparticles in Biology and Medicine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Water Soluble Gold Nanoparticles
    Oil Soluble Gold Nanoparticles
    Both Phase Soluble Gold Nanoparticles
    Market segment by Application
    Biology
    Medicine
    Major players covered
    Nanopartz
    Nanocs
    nanoComposix
    BBI Solutions
    Cline Scientific
    Cytodiagnostics
    Sigma Aldrich
    Tanaka Technologies
    Expedeon
    NanoSeedz
    NanoHybrids
    Hongwu New Material
    Metalor Technologies SA
    Solaris Nanoscinces
    Meliorum Technologies
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Gold Nanoparticles in Biology and Medicine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Gold Nanoparticles in Biology and Medicine, with price, sales quantity, revenue, and global market share of Gold Nanoparticles in Biology and Medicine from 2020 to 2025.
    Chapter 3, the Gold Nanoparticles in Biology and Medicine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Gold Nanoparticles in Biology and Medicine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Gold Nanoparticles in Biology and Medicine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Gold Nanoparticles in Biology and Medicine.
    Chapter 14 and 15, to describe Gold Nanoparticles in Biology and Medicine sales channel, distributors, customers, research findings and conclusion.

    Buy now